122 related articles for article (PubMed ID: 31179578)
41. Preventing CLABSIs among pediatric hematology/oncology inpatients: national collaborative results.
Bundy DG; Gaur AH; Billett AL; He B; Colantuoni EA; Miller MR;
Pediatrics; 2014 Dec; 134(6):e1678-85. PubMed ID: 25404721
[TBL] [Abstract][Full Text] [Related]
42. CLABSI Risk Factors in the NICU: Potential for Prevention: A PICNIC Study.
Dahan M; O'Donnell S; Hebert J; Gonzales M; Lee B; Chandran AU; Woolsey S; Escoredo S; Chinnery H; Quach C
Infect Control Hosp Epidemiol; 2016 Dec; 37(12):1446-1452. PubMed ID: 27609629
[TBL] [Abstract][Full Text] [Related]
43. Clinical Characteristics and Risk Factors of Long-term Central Venous Catheter-associated Bloodstream Infections in Children.
Moon HM; Kim S; Yun KW; Kim HY; Jung SE; Choi EH; Lee HJ
Pediatr Infect Dis J; 2018 May; 37(5):401-406. PubMed ID: 29194165
[TBL] [Abstract][Full Text] [Related]
44. Development of a Clinical Prediction Model for Central Line-Associated Bloodstream Infection in Children Presenting to the Emergency Department.
Figueroa-Phillips LM; Bonafide CP; Coffin SE; Ross ME; Guevara JP
Pediatr Emerg Care; 2020 Nov; 36(11):e600-e605. PubMed ID: 30985631
[TBL] [Abstract][Full Text] [Related]
45. Multicenter study in Colombia: Impact of a multidimensional International Nosocomial Infection Control Consortium (INICC) approach on central line-associated bloodstream infection rates.
Álvarez-Moreno CA; Valderrama-Beltrán SL; Rosenthal VD; Mojica-Carreño BE; Valderrama-Márquez IA; Matta-Cortés L; Gualtero-Trujillo SM; Rodríguez-Peña J; Linares-Miranda CJ; Gonzalez-Rubio ÁP; Vega-Galvis MC; Riaño-Forero I; Ariza-Ayala BE; García-Laverde G; Susmann O; Mancera-Páez O; Olarte N; Rendón-Campo LF; Astudillo Y; Trullo-Escobar MD; Orellano PW
Am J Infect Control; 2016 Nov; 44(11):e235-e241. PubMed ID: 27317408
[TBL] [Abstract][Full Text] [Related]
46. Risk factors for central line-associated bloodstream infections in children with tunneled central venous catheters.
Paioni P; Kuhn S; Strässle Y; Seifert B; Berger C
Am J Infect Control; 2020 Jan; 48(1):33-39. PubMed ID: 31395289
[TBL] [Abstract][Full Text] [Related]
47. Appropriate duration of peripherally inserted central catheter maintenance to prevent central line-associated bloodstream infection.
Park S; Moon S; Pai H; Kim B
PLoS One; 2020; 15(6):e0234966. PubMed ID: 32569313
[TBL] [Abstract][Full Text] [Related]
48. Impact of the International Nosocomial Infection Control Consortium (INICC)'s Multidimensional Approach on Rates of Central Line-Associated Bloodstream Infection in 14 Intensive Care Units in 11 Hospitals of 5 Cities in Argentina.
Rosenthal VD; Desse J; Maurizi DM; Chaparro GJ; Orellano PW; Chediack V; Cabrera R; Golschmid D; Silva CG; Vimercati JC; Stagnaro JP; Perez I; Spadaro ML; Montanini AM; Pedersen D; Paniccia TL; Aguilera AMR; Cermesoni R; Mele JI; Alda E; Paldoro AE; Ortta AR; Cooke B; García MC; Obed MN; Domínguez CV; Saúl PA; Rodríguez Del Valle MC; Bianchi AC; Alvarez G; Pérez R; Oyola C
Infect Control Hosp Epidemiol; 2018 Apr; 39(4):445-451. PubMed ID: 29427997
[TBL] [Abstract][Full Text] [Related]
49. Rate and time to develop first central line-associated bloodstream infections when comparing open and closed infusion containers in a Brazilian Hospital.
Vilins M; Blecher S; Silva MA; Rosenthal VD; Barker K; Salomao R
Braz J Infect Dis; 2009 Oct; 13(5):335-40. PubMed ID: 20428631
[TBL] [Abstract][Full Text] [Related]
50. Ethanol lock therapy to reduce the incidence of catheter-related bloodstream infections in home parenteral nutrition patients with intestinal failure: preliminary experience.
Wales PW; Kosar C; Carricato M; de Silva N; Lang K; Avitzur Y
J Pediatr Surg; 2011 May; 46(5):951-6. PubMed ID: 21616259
[TBL] [Abstract][Full Text] [Related]
51. Incidence, risk factors and healthcare costs of central line-associated nosocomial bloodstream infections in hematologic and oncologic patients.
Baier C; Linke L; Eder M; Schwab F; Chaberny IF; Vonberg RP; Ebadi E
PLoS One; 2020; 15(1):e0227772. PubMed ID: 31978169
[TBL] [Abstract][Full Text] [Related]
52. The influence of intensive care unit-acquired central line-associated bloodstream infection on in-hospital mortality: A single-center risk-adjusted analysis.
Wong SW; Gantner D; McGloughlin S; Leong T; Worth LJ; Klintworth G; Scheinkestel C; Pilcher D; Cheng AC; Udy AA
Am J Infect Control; 2016 May; 44(5):587-92. PubMed ID: 26874406
[TBL] [Abstract][Full Text] [Related]
53. Clinical impact and cost-effectiveness of split-septum and single-use prefilled flushing device vs 3-way stopcock on central line-associated bloodstream infection rates in India: a randomized clinical trial conducted by the International Nosocomial Infection Control Consortium (INICC).
Rosenthal VD; Udwadia FE; Kumar S; Poojary A; Sankar R; Orellano PW; Durgad S; Thulasiraman M; Bahirune S; Kumbhar S; Patil P
Am J Infect Control; 2015 Oct; 43(10):1040-5. PubMed ID: 26164769
[TBL] [Abstract][Full Text] [Related]
54. Is zero central line-associated bloodstream infection rate sustainable? A 5-year perspective.
Erdei C; McAvoy LL; Gupta M; Pereira S; McGowan EC
Pediatrics; 2015 Jun; 135(6):e1485-93. PubMed ID: 25986020
[TBL] [Abstract][Full Text] [Related]
55. Central line-associated bloodstream infections in non-ICU inpatient wards: a 2-year analysis.
Rhee Y; Heung M; Chen B; Chenoweth CE
Infect Control Hosp Epidemiol; 2015 Apr; 36(4):424-30. PubMed ID: 25782897
[TBL] [Abstract][Full Text] [Related]
56. Impact of mucosal barrier injury laboratory-confirmed bloodstream infection (MBI-LCBI) on central line-associated bloodstream infections (CLABSIs) in department of hematology at single university hospital in Japan.
Kato Y; Hagihara M; Kurumiya A; Takahashi T; Sakata M; Shibata Y; Kato H; Shiota A; Watanabe H; Asai N; Koizumi Y; Yamagishi Y; Mikamo H
J Infect Chemother; 2018 Jan; 24(1):31-35. PubMed ID: 29066217
[TBL] [Abstract][Full Text] [Related]
57. Changes in Central Line-Associated Bloodstream Infection Rates Among Children With Immune Compromised Conditions: An 11-Year Review.
Linder LA; Gerdy C; Jo Y; Wilson A
J Pediatr Oncol Nurs; 2018; 35(6):382-391. PubMed ID: 29665727
[TBL] [Abstract][Full Text] [Related]
58. The efficacy of alcohol-antibiotic lock therapy for treatment of catheter related bloodstream infections in patients receiving home parenteral nutrition.
Ławiński M; Majewska K; Fołtyn I; Gradowska A
Pol Przegl Chir; 2015 Mar; 86(12):563-8. PubMed ID: 25803055
[TBL] [Abstract][Full Text] [Related]
59. Central Line-Associated Bloodstream Infection Reduction and Bundle Compliance in Intensive Care Units: A National Study.
Furuya EY; Dick AW; Herzig CT; Pogorzelska-Maziarz M; Larson EL; Stone PW
Infect Control Hosp Epidemiol; 2016 Jul; 37(7):805-10. PubMed ID: 27052993
[TBL] [Abstract][Full Text] [Related]
60. Impact of switching from an open to a closed infusion system on rates of central line-associated bloodstream infection: a meta-analysis of time-sequence cohort studies in 4 countries.
Maki DG; Rosenthal VD; Salomao R; Franzetti F; Rangel-Frausto MS
Infect Control Hosp Epidemiol; 2011 Jan; 32(1):50-8. PubMed ID: 21121815
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
